TY - CHAP
T1 - Pharmacological Therapies in Alzheimer's Disease
AU - Steinberg, Martin
AU - Lyketsos, Constantine G.
PY - 2010/12/2
Y1 - 2010/12/2
KW - Alzheimer's disease (AD), progressive neurodegenerative disorder - deterioration in cognition and functioning, and neuropsychiatric co-morbidity
KW - Cognition and function deterioration - and neuronal system degeneration
KW - Common and less common side effects - of cholinesterase inhibitors and memantine
KW - Donepezil and oral rivastigmine - in treatment of mild to moderate AD
KW - Galantamine, FDA approved in 2001 - treatment of mild to moderately severe AD
KW - Memantine trial, in patients - with moderate to severe AD
KW - Neuropsychiatric effects of cholinesterase inhibitors and memantine
KW - Pharmacological therapies - in Alzheimer's disease
KW - Side effects of galantamine - identical to those of donepezil
KW - Switching acetylcholinesterase inhibitors
UR - http://www.scopus.com/inward/record.url?scp=84885761170&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885761170&partnerID=8YFLogxK
U2 - 10.1002/9780470669600.ch52
DO - 10.1002/9780470669600.ch52
M3 - Chapter
AN - SCOPUS:84885761170
SN - 9780470747230
SP - 304
EP - 311
BT - Principles and Practice of Geriatric Psychiatry
PB - John Wiley and Sons
ER -